A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability

Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care

(2018) Eran Ben-Arye et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

(2018) Jeremy M. O’Connor et al.   JAMA Oncology

Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy

(2018) David Levy et al.   SUPPORTIVE CARE IN CANCER

Health-related quality of life results from the phase III CheckMate 067 study

(2017) Dirk Schadendorf et al.   EUROPEAN JOURNAL OF CANCER

Feasibility and acceptability of the use of patient-reported outcome measures (PROMs) in the delivery of nurse-led supportive care to people with colorectal cancer

(2017) Grigorios Kotronoulas et al.   European Journal of Oncology Nursing

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

(2017) Jacob Schachter et al.   LANCET

Integrative Oncology

(2017) Gabriel Lopez et al.   MEDICAL CLINICS OF NORTH AMERICA

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

(2017) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Colorectal cancer patient’s self-efficacy for managing illness-related problems in the first 2 years after diagnosis, results from the ColoREctal Well-being (CREW) study

(2017) Chloe Grimmett et al.   Journal of Cancer Survivorship

Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: Evaluating patient acceptability.

(2017) Hannah Solomon et al.   JOURNAL OF CLINICAL ONCOLOGY

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

(2016) Thomas K. Eigentler et al.   CANCER TREATMENT REVIEWS

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

(2015) Kathleen M. Mahoney et al.   CLINICAL THERAPEUTICS

Cancer-Related Fatigue, Version 2.2015

(2015) Ann M. Berger et al.   Journal of the National Comprehensive Cancer Network

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pembrolizumab

(2015) Leila Khoja et al.   Journal for ImmunoTherapy of Cancer

Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation

(2014) Julienne E. Bower et al.   JOURNAL OF CLINICAL ONCOLOGY

What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials

(2014) Grigorios Kotronoulas et al.   JOURNAL OF CLINICAL ONCOLOGY

Living with advanced cancer and an uncertain disease trajectory: an emerging patient population in palliative care?: Table 1

(2013) Elizabeth A Lobb et al.   BMJ Supportive & Palliative Care

The ToT Study: Helping with Touch or Talk (ToT): a pilot randomised controlled trial to examine the clinical effectiveness of aromatherapy massage versus cognitive behaviour therapy for emotional distress in patients in cancer/palliative care

(2011) M. Serfaty et al.   PSYCHO-ONCOLOGY

The unfulfilled promise: a systematic review of interventions to reduce the unmet supportive care needs of cancer patients

(2011) Mariko Carey et al.   SUPPORTIVE CARE IN CANCER

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

(2010) Jennifer S. Temel et al.   NEW ENGLAND JOURNAL OF MEDICINE

What are the unmet supportive care needs of people with cancer? A systematic review

(2009) James D. Harrison et al.   SUPPORTIVE CARE IN CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy-General (FACT-G)

(2008) Monika Janda et al.   PSYCHO-ONCOLOGY